Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.0100 (22.1%) ($13.0100 - $13.0100) on Thu. May. 6, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.6% (three month average) | RSI | 66 | Latest Price | $13.0100(22.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(37%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -2.8% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-1%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.8% (StdDev 5.6%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $11.48(13.33%) | 10 Day Moving Average | $11.87(9.6%) | 20 Day Moving Average | $11.4(14.12%) | To recent high | -4.5% | To recent low | 41.5% | Market Cap | $2.295b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |